BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 338576)

  • 1. Genetics of nitrofurazone resistance in Escherichia coli.
    McCalla DR; Kaiser C; Green MH
    J Bacteriol; 1978 Jan; 133(1):10-6. PubMed ID: 338576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
    Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB
    J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the role played by NfsA, NfsB nitroreductase and NemA flavin reductase from Escherichia coli in the conversion of ethyl 2-(2'-nitrophenoxy)acetate to 4-hydroxy-(2H)-1,4-benzoxazin-3(4H)-one (D-DIBOA), a benzohydroxamic acid with interesting biological properties.
    Valle A; Le Borgne S; Bolívar J; Cabrera G; Cantero D
    Appl Microbiol Biotechnol; 2012 Apr; 94(1):163-71. PubMed ID: 22173483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on 1-nitropyrene and nitrofurazone reductases in Escherichia coli.
    Narai N; Kitamura S; Tatsumi K
    J Pharmacobiodyn; 1984 Jun; 7(6):407-13. PubMed ID: 6384469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen-insensitive nitroreductase E. coli NfsA, but not NfsB, is inhibited by fumarate.
    Day MA; Jarrom D; Rajah N; Searle PF; Hyde EI; White SA
    Proteins; 2023 May; 91(5):585-592. PubMed ID: 36443029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of major Escherichia coli reductases involved in aerobic nitro and azo reduction.
    Mercier C; Chalansonnet V; Orenga S; Gilbert C
    J Appl Microbiol; 2013 Oct; 115(4):1012-22. PubMed ID: 23795903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residue Phe42 is critical for the catalytic activity of Escherichia coli major nitroreductase NfsA.
    Yang J; Zhan J; Bai J; Liu P; Xue Y; Yang Q
    Biotechnol Lett; 2013 Oct; 35(10):1693-700. PubMed ID: 23801116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase.
    Zenno S; Koike H; Kumar AN; Jayaraman R; Tanokura M; Saigo K
    J Bacteriol; 1996 Aug; 178(15):4508-14. PubMed ID: 8755878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
    Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954.
    Jarrom D; Jaberipour M; Guise CP; Daff S; White SA; Searle PF; Hyde EI
    Biochemistry; 2009 Aug; 48(32):7665-72. PubMed ID: 19580253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2.
    García V; Montero I; Bances M; Rodicio R; Rodicio MR
    Microb Drug Resist; 2017 Jun; 23(4):405-412. PubMed ID: 27809653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen-insensitive nitroreductases NfsA and NfsB of Escherichia coli function under anaerobic conditions as lawsone-dependent Azo reductases.
    Rau J; Stolz A
    Appl Environ Microbiol; 2003 Jun; 69(6):3448-55. PubMed ID: 12788749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrofurazone-reducing enzymes in E. coli and their role in drug activation in vivo.
    McCalla DR; Olive P; Tu Y; Fan ML
    Can J Microbiol; 1975 Oct; 21(10):1484-91. PubMed ID: 136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
    Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T
    Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations to nitrofurantoin and nitrofurazone resistance in Escherichia coli K12.
    Breeze AS; Obaseiki-Ebor EE
    J Gen Microbiol; 1983 Jan; 129(1):99-103. PubMed ID: 6339681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and analysis of furazolidone-resistant Escherichia coli mutants.
    Martínez-Puchol S; Gomes C; Pons MJ; Ruiz-Roldán L; Torrents de la Peña A; Ochoa TJ; Ruiz J
    APMIS; 2015 Aug; 123(8):676-81. PubMed ID: 26011027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of nitrofurazone.
    McCalla DR; Reuvers A; Kaiser C
    J Bacteriol; 1970 Dec; 104(3):1126-34. PubMed ID: 16559085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmonella typhimurium mutagenicity tester strains that overexpress oxygen-insensitive nitroreductases nfsA and nfsB.
    Carroll CC; Warnakulasuriyarachchi D; Nokhbeh MR; Lambert IB
    Mutat Res; 2002 Apr; 501(1-2):79-98. PubMed ID: 11934440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residues.
    Hall KR; Robins KJ; Williams EM; Rich MH; Calcott MJ; Copp JN; Little RF; Schwörer R; Evans GB; Patrick WM; Ackerley DF
    Elife; 2020 Nov; 9():. PubMed ID: 33185191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen-insensitive nitroreductases of Escherichia coli do not reduce 3-nitrotyrosine.
    Lightfoot RT; Shuman D; Ischiropoulos H
    Free Radic Biol Med; 2000 Apr; 28(7):1132-6. PubMed ID: 10832075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.